Dennis McCarty, Ph.D.
- Professor, OHSU-PSU School of Public Health
Biography
Dennis McCarty, Ph.D., a Professor in the Department of Public Health & Preventive Medicine at Oregon Health & Science University, works at the intersection of policy, research and practice assessing the organization, financing, and quality of prevention and treatment services for alcohol and drug disorders. He serves as the Director of the Education Core for the Methamphetamine Abuse Research Center (P50 DA018165), the co-Principal Investigator for the Western States Node of the National Drug Abuse Treatment Clinical Trials Network (U10 DA015815), and the Principal Investigator for an evaluation of the impacts of Oregon’s Coordinated Care Organizations on prevention and treatment for alcohol and drug use disorders (R33 DA035640). Dr. McCarty is the Academic Director for the University of Amsterdam’s Summer Institute on Alcohol, Drugs and Addiction – a two week course that uses Dutch policy perspectives on drug use disorders to introduce the neuroscience, genetics, treatment and prevention of alcohol and drug use disorders. Between 1989 and 1995, Dr. McCarty directed the Massachusetts Bureau of Substance Abuse Services for the Massachusetts Department of Public Health. Currently, he serves on the Oregon Alcohol and Drug Policy Commission and the Governor’s Task Force on Prescription Drug Misuse and Abuse. He received a doctorate in social psychology from the University of Kentucky.
Education and training
-
Degrees
- B.A., 1971, University of Kentucky
- M.A., 1976, University of Kentucky
- Ph.D., 1978, University of Kentucky
Additional information
Publications
Publications
Opioid Treatment Programs and Risks for COVID-19 Infections, Emergency Visits, and Hospitalizations
Journal of general internal medicineOregon’s Emerging Psilocybin Services Workforce
Journal of psychoactive drugsAddiction severity and re-employment in Sweden among adults with risky alcohol and drug use
Journal of Substance Use and Addiction TreatmentBuprenorphine discontinuation in telehealth-only treatment for opioid use disorder
Journal of Substance Use and Addiction TreatmentDeveloping the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services
Journal of PsychopharmacologyEffects Of Medicaid Waivers On Use Of Medications For Opioid Use Disorder And Nonfatal Overdoses In 17 States
Health AffairsEngaging the great circle
Annals of MedicinePersonal Psychedelic Experience as a Training Qualification for Facilitators
Journal of psychoactive drugsPrescription Opioid Dose Reductions and Potential Adverse Events
Journal of general internal medicineUsability and feasibility of a take-home methadone web-application for opioid treatment program patients
Journal of Substance Use and Addiction TreatmentRecruitment challenges for a prospective telehealth cohort study
Contemporary Clinical Trials CommunicationsState- and County-Level Geographic Variation in Opioid Use Disorder, Medication Treatment, and Opioid-Related Overdose among Medicaid Enrollees
JAMA Health ForumAssociation between treatment setting and outcomes among oregon medicaid patients with opioid use disorder
Addiction Science and Clinical PracticeDevelopment and implementation of a prescription opioid registry across diverse health systems
JAMIA OpenDevelopment and validation of health system performance measures for opioid use disorder in British Columbia, Canada
Drug and Alcohol DependenceDifferences in the delivery of medications for opioid use disorder during hospitalization by racial categories
Substance AbuseExpanding Inpatient Addiction Consult Services Through Accountable Care Organizations for Medicaid Enrollees
Journal of addiction medicineFrequency and recency of non-medical opioid use and death due to overdose or suicide among individuals assessed for risky substance use
Journal of Substance Abuse TreatmentHIV clinic-based extended-release naltrexone versus treatment as usual for people with HIV and opioid use disorder
AddictionHospital Admission Rate, Cumulative Hospitalized Days, and Time to Admission Among Older Persons With Substance Use and Psychiatric Conditions
Frontiers in PsychiatryIntroduction to a Special Issue
Journal of Substance Abuse TreatmentRecurrent risk of hospitalization among older people with problematic alcohol use
AddictionTreatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs
Journal of Substance Abuse TreatmentHospital policies for opioid use disorder treatment
General Hospital PsychiatryInterim methadone – Effective but underutilized
Drug and Alcohol Dependence